ChemADVISOR, Inc. – Trademark Portfolio

Entity Type: 03

ChemADVISOR, Inc. holds 11 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 10 filings in this category. The portfolio also extends into Class 45 (Legal & Security Services) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include LOLI. The owner is based in Pittsburgh, PA.

750 William Pitt Way

Pittsburgh, PA 152381333

11 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

ChemADVISOR, Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

9
Computers & Electronics (10 filings)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

45
Legal & Security Services (1 filing)

Legal services; security services for the protection of property and individuals

Frequently Asked Questions

How many trademarks does ChemADVISOR, Inc. have?

ChemADVISOR, Inc. has 11 U.S. trademarks filed with the USPTO. Of these, 1 registered, 2 abandoned, 8 cancelled.

What trademark classes does ChemADVISOR, Inc. file in?

ChemADVISOR, Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 45 (Legal & Security Services). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.

What are ChemADVISOR, Inc.'s most well-known trademarks?

ChemADVISOR, Inc.'s registered trademark portfolio includes well-known marks such as LOLI. These are among 1 currently registered trademark in the portfolio.

What is ChemADVISOR, Inc.'s trademark registration success rate?

ChemADVISOR, Inc. has a 9% trademark registration rate, with 1 out of 11 resolved applications resulting in successful registration. Currently, 0 applications are pending review.